Adults with T2DM have high odds of periodontitis, and serum PLP may play a modulatory effect in this association, as ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Medically reviewed by Danielle Weiss, MD Type 2 diabetes mellitus (T2DM) occurs when the body cannot use insulin properly, ...

Continuing our series highlighting recent presentations from Nursing in Practice 365 events, diabetes specialist midwife ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

Medium and high type 2 diabetes (T2D) genetic risks are not associated with an increased risk for atherosclerotic ...

The researchers highlighted the importance of incorporating the Trabecular Bone Score alongside aBMD assessments for a more ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.

The following is a summary of “Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related ...